Cargando…
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients
PURPOSE OF REVIEW: The role of renin-angiotensin-aldosterone system (RAAS) inhibitors, notably angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARBs), in the COVID-19 pandemic has not been fully evaluated. With an increasing number of COVID-19 cases worldwide, it is...
Autores principales: | Baral, Ranu, White, Madeline, Vassiliou, Vassilios S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443394/ https://www.ncbi.nlm.nih.gov/pubmed/32830286 http://dx.doi.org/10.1007/s11883-020-00880-6 |
Ejemplares similares
-
Percutaneous Coronary Intervention Versus Medical Therapy for Chronic Total Occlusion of Coronary Arteries: A Systematic Review and Meta-Analysis
por: Li, Ka Hou Christien, et al.
Publicado: (2019) -
The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project
por: Ceska, Richard, et al.
Publicado: (2019) -
The Role of Emerging Risk Factors in Cardiovascular Outcomes
por: Lacey, Ben, et al.
Publicado: (2017) -
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022) -
Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis
por: Baral, Ranu, et al.
Publicado: (2021)